Jazz Pharmaceuticals PLC Financial Flexibility Index
Jazz Pharmaceuticals PLC financial flexibility index. Jazz Pharmaceuticals PLC (JAZZ) has a Financial Flexibility Index of 0.06x as of March 2026. Free cash flow of $427.90 Million (operating CF $408.20 Million minus capex $19.70 Million) represents 0% of total liabilities ($7.33 Billion). Explore capital reinvestment ratio of Jazz Pharmaceuticals PLC to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jazz Pharmaceuticals PLC (2005–2025)
Financial flexibility index of Jazz Pharmaceuticals PLC from 2005 to 2025. Historical Financial Flexibility Index trend for Jazz Pharmaceuticals PLC across 21 annual periods. Check JAZZ total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Jazz Pharmaceuticals PLC Financial Flexibility Index by Year (2005–2025)
Jazz Pharmaceuticals PLC financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Jazz Pharmaceuticals PLC. For the full cash flow conversion analysis, see cash flow conversion of Jazz Pharmaceuticals PLC.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.41 Billion | $1.36 Billion | $7.34 Billion | ▲ +5.7% |
| 2024 | 0.18x | $1.44 Billion | $1.40 Billion | $7.92 Billion | ▲ +25.1% |
| 2023 | 0.15x | $1.12 Billion | $1.09 Billion | $7.66 Billion | ▼ -36.2% |
| 2022 | 0.23x | $1.77 Billion | $1.27 Billion | $7.75 Billion | ▲ +131.0% |
| 2021 | 0.10x | $824.04 Million | $778.51 Million | $8.33 Billion | ▼ -77.8% |
| 2020 | 0.44x | $1.28 Billion | $899.65 Million | $2.88 Billion | ▲ +12.6% |
| 2019 | 0.39x | $958.74 Million | $776.40 Million | $2.43 Billion | ▲ +3.8% |
| 2018 | 0.38x | $930.37 Million | $798.90 Million | $2.45 Billion | ▲ +13.6% |
| 2017 | 0.33x | $807.04 Million | $693.09 Million | $2.41 Billion | ▲ +26.7% |
| 2016 | 0.26x | $772.12 Million | $590.54 Million | $2.92 Billion | ▼ -18.1% |
| 2015 | 0.32x | $567.90 Million | $531.94 Million | $1.76 Billion | ▼ -1.6% |
| 2014 | 0.33x | $644.74 Million | $405.76 Million | $1.97 Billion | ▲ +4.7% |
| 2013 | 0.31x | $294.89 Million | $283.62 Million | $942.69 Million | ▼ -2.9% |
| 2012 | 0.32x | $272.23 Million | $249.75 Million | $845.20 Million | ▼ -87.6% |
| 2011 | 2.59x | $157.38 Million | $151.60 Million | $60.78 Million | ▲ +328.2% |
| 2010 | 0.60x | $63.60 Million | $58.87 Million | $105.18 Million | ▲ +1209.2% |
| 2009 | -0.05x | $-9.82 Million | $-15.88 Million | $180.23 Million | ▲ +88.7% |
| 2008 | -0.48x | $-101.49 Million | $-130.23 Million | $210.38 Million | ▲ +5.6% |
| 2007 | -0.51x | $-77.94 Million | $-81.09 Million | $152.56 Million | ▼ -258.7% |
| 2006 | -0.14x | $-55.67 Million | $-57.35 Million | $390.87 Million | ▲ +20.6% |
| 2005 | -0.18x | $-50.75 Million | $-52.16 Million | $283.03 Million | — |